Development of a standardized definition for clinically significant bleeding in the ASPirin in Reducing Events in the Elderly (ASPREE) trial

BACKGROUND: Bleeding is the major risk of aspirin treatment, especially in the elderly. A consensus definition for clinically significant bleeding (CSB) in aspirin primary prevention trials is lacking in the literature. METHODS: This paper details the development, modification, application, and qual...

Descripción completa

Detalles Bibliográficos
Autores principales: Margolis, Karen L., Mahady, Suzanne E., Nelson, Mark R., Ives, Diane G., Satterfield, Suzanne, Britt, Carlene, Ekram, Saifuddin, Lockery, Jessica, Schwartz, Erin C., Woods, Robyn L., McNeil, John J., Wood, Erica M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022241/
https://www.ncbi.nlm.nih.gov/pubmed/30023457
http://dx.doi.org/10.1016/j.conctc.2018.05.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6022241/
https://www.ncbi.nlm.nih.gov/pubmed/30023457
http://dx.doi.org/10.1016/j.conctc.2018.05.015

Ejemplares similares